Old Web
English
Sign In
Acemap
>
authorDetail
>
Pablo Cagnoni
Pablo Cagnoni
OSI Pharmaceuticals
Biology
Immunology
Protein kinase B
Erlotinib
Cancer
3
Papers
267
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition.
2007
Molecular Cancer Therapeutics
Elizabeth Buck
Alexandra Eyzaguirre
Sharon Barr
Stuart Thompson
Regina Sennello
David Young
Kenneth K. Iwata
Neil W. Gibson
Pablo Cagnoni
John D. Haley
Show All
Source
Cite
Save
Citations (163)
Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity
2006
Molecular Cancer Therapeutics
Elizabeth Buck
Alexandra Eyzaguirre
John D. Haley
Neil W. Gibson
Pablo Cagnoni
Kenneth K. Iwata
Show All
Source
Cite
Save
Citations (104)
Proteomic and IHC measurements of cellular sensitivity to EGF receptor kinase inhibitors
2006
Clinical Cancer Research
Stuart Thomson
Filippo Petti
Elizabeth Buck
Sharon Barr
Alexandra Eyzaguirre
Gina Sennello
David Young
Ken Iwata
Pablo Cagnoni
Neil W. Gibson
John D. Haley
Show All
Source
Cite
Save
Citations (0)
1